Study finds general public is willing to fund DMD treatment
A recent study found that members of the general public are willing to pay increased taxes to cover the costs of a novel DMD treatment.
News
-
-
Gene therapy Elevidys shows promise for DMD, but questions remain
While the therapy is promising, recent studies suggest that its benefits may be limited and carry potential risks.
-
Forskolin shows promise in DMD treatment, but more research is needed
The plant-derived compound may shows therapeutic potential for DMD, but more research is needed to minimize its risks.
-
New data suggests gene therapy preserves muscle health in boys with DMD
Boys with DMD who received the treatment showed significantly less fat replacement and tissue damage in key leg muscles.
-
DMD affects the heart before any symptoms appear, study finds
Changes to the heart’s normal function due to DMD can be caught early on using a simple, non-invasive test called a Lead II ECG.
-
Muscle contractures linked to gait abnormalities in DMD
Muscle contractures contribute significantly to walking (gait) abnormalities in patients with Duchenne muscular dystrophy (DMD).
-
Gut bacteria may be linked to intellectual disabilities in Duchenne muscular dystrophy
The analysis showed significant differences in the gut microbiota of individuals with DMD with and without an intellectual disability.
-
Home ventilation slows respiratory deterioration in DMD
Initiation of home mechanical ventilation around the age of 20 appears to slow respiratory deterioration in patients with DMD.
-
Long-term cardiac effects of glucocorticoids in DMD uncertain
A recent literature review of the effects of glucocorticoid therapy on cardiovascular health in patients with DMD showed mixed findings.
-
New biomarker may enhance early detection of Duchenne muscular dystrophy
A new study found a protein lower in DMD carriers may serve as a useful biomarker in screening for the disease.
